Skip Navigation

Faculty Profiles

Robert Guyton

Robert A. Guyton, MD

Distinguished Charles Ross Hatcher, Jr., Professor of Surgery

Program Director, Three Year Cardiothoracic Surgery Residency, Emory University School of Medicine

Director, Cardiothoracic Research Lab (CTRL), Division of Cardiothoracic Surgery, Emory University School of Medicine

Chief of Cardiothoracic Surgery, Emory University Hospital

Telephone

404.778.5040

Email

rguyton@emory.edu

Certification

American Board of Surgery, American Board of Thoracic Surgery

Year Joined Emory as a Faculty Member

1980

Bio-Summary

Dr. Guyton served as chief of the Division of Cardiothoracic Surgery at Emory from 1990-2017. Under his guidance, Emory's CT surgery program achieved national recognition as one of the country's top programs in areas including off-pump coronary revascularization, congenital cardiac surgery, robotic mitral surgery, major aortic surgery, robotic-assisted coronary bypass, and transcatheter aortic valve replacement.

Dr. Guyton has influenced his field in other fundamental ways as well. For almost three decades, he has been responsible for the education of some of the most accomplished and successful CT surgeons in the country, participating in the training of more than 140 resident physicians. Emory's CT surgery residency program accounts for approximately 5% of all active cardiac surgeons in the country today.

In 2007, Dr. Guyton joined Emory CT surgeon scientist Dr. Vinod Thourani and Emory cardiologists Dr. Vasilis Babaliaros and Dr. Peter Block as one of the local surgical Co-PIS of the multi-center PARTNER I trial of transcatheter aortic valve replacement (TAVR). The results of the national trial influenced FDA approval of the SAPIEN transfemoral transcatheter heart valve for treatment of high-risk patients with aortic stenosis in 2011.

In 2014, Dr. Guyton was inducted into Emory's Millipub Club for being co-author of a paper that has been cited more than 1,000 times in the literature. The paper, "Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery," was published in the October 2010 edition of New England Journal of Medicine, and it reported the results of comparing TAVR to such standard therapies as balloon aortic valvuloplasty. Dr. Guyton and his co-authors concluded that the reduced mortality among patients treated with TAVR as opposed to traditional methods was significant.

Publications

View Dr. Guytons's publications in PubMed.

Affiliations

Medical School

Postgraduate Training

Honors and Awards

Current Organizational Memberships

Editorial Boards

Clinical and Research Interests

««return to top